Navigation Links
REP8839 in Medical News

Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839

Replidyne, Inc. today announced results from three Phase I trials studying REP8839, a novel topical antibiotic that has shown potent in vitro activity against major skin pathogens including methicillin-resistant S. aureus (MRSA). The results of the Phase I trials show that topically applie...

Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

...acillus anthracis (BA) Inhalation Post-Exposure Prophylaxis Model." rep8839 Presentation Thursday, September 20 at 10:00 AM, Room E253D: -- Poster F1-2116, titled "In vitro Activity of rep8839 against Pasteurella species and Other Fastidious Bacteria Isolated fro...
REP8839 in Medical Technology

Replidyne Provides Strategic Update

... inhibition program. As a result of prioritizing these preclinical programs, Replidyne has suspended the development of topical antibiotic rep8839 due to the additional investment required to optimize the formulation and the niche market opportunity. -- Development strategy for faropenem. R...

Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839

... of the Phase I trials show that topically applied rep8839 appears safe, well-tolerated and associated with l...hase II trials to study the safety and efficacy of rep8839 in patients with impetigo and other skin and wound infections." rep8839 was tested in three Phase I trials which collectiv...
REP8839 in Biological Technology

Replidyne Announces Second Quarter 2008 Results From Operations

...eplidyne's discovery research programs, primarily the C. difficile and DNA replication inhibition programs, offset by decreased expense related to the rep8839 program that was suspended in December 2007. Sales, general and administrative expenses for the second quarter of 2008 were $4.7 million compared to...

Replidyne Announces 2007 Fourth Quarter and Full Year Results

...lidyne's discovery research programs, primarily its C. difficile and inhibition of DNA replication programs offset by decreased expense related to the rep8839 program that was suspended in December 2007. Research and development expense was $43.3 million for the full year 2007 compared to $38.3 million in 20...
Other Tags
(Date:4/18/2014)... psychologists have made a brain-related discovery that could ... , This discovery opens up the possibility that ... a specific brain activity that the researchers have ... Journal of Neuroscience has just published ... an associate professor of psychology and his doctoral ...
(Date:4/18/2014)... by Northwestern Medicine scientists could lead to potential new ... people with scleroderma. , Fibrosis, or scarring, is ... the skin and lungs can lead to serious organ ... for new therapeutic options centers on findings made by ... identified the role that a specific protein plays in ...
(Date:4/17/2014)... have identified the first genetic variant specifically associated ... accounting for around 10-15 per cent of all ... of the breast cancer sub-type, called invasive lobular ... causes of this particular kind of breast cancer, ... research, published today (Thursday) in the journal ...
(Date:4/17/2014)... published today in PLOS Pathogens , children who ... common can mount an immune response to infection with ... bouts of high fever and illness and partially control ... findings may help researchers develop future interventions that prevent ... , Each year, approximately 200 million cases of malaria ...
(Date:4/17/2014)... Two recent papers by a University of ... help scientists develop treatments or vaccines for Dengue ... and other disease-causing flaviviruses. , Jeffrey S. Kieft, ... at the School of Medicine and an early ... and colleagues recently published articles in the scholarly ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2
(Date:4/17/2014)... West Orange, NJ. April 16, 2014. Kessler Foundation ... for $1.8 million from the Department of Defense ... PhD, is principal investigator for the randomized, double-blinded, ... to improve bone and muscle strength after spinal ... Human Performance & Engineering Research at Kessler Foundation. ...
(Date:4/17/2014)... anthrax detection cartridge developed at Sandia National Laboratories and ... easier, faster and cheaper. , Bacillus anthracis ... in soils all over the world and can cause ... animals. The bacteria can survive in harsh conditions for ... may occur through skin contact, inhalation of spores or ...
(Date:4/17/2014)... Kansas State University engineer has developed a patented ... improvised explosive devices. The same technique could help ... Steven M. and Kay L. Theede chair in ... engineering, and his research team have created a ... in car trunks. The distance detection method ...
Breaking Biology News(10 mins):Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3Patented research remotely detects nitrogen-rich explosives 2
Other Contents